Home » Newsletters » BioWorld Science

BioWorld Science

July 26, 1999

View Archived Issues

Kurtoxin-1 available for licensing from NIH

Licensing/CRADA opportunity from NIH: eosinophil-derived neutralizing agent

Recombinant Velosulin BR approved in U.S. for diabetes

Amgen presents Q2 highlights

Draxis Health completes acquisition of eight Elan neurology products

Valentis initiates phase I/II trial of IL-12 gene therapy

Q2 results, clinical progress reported by Icos

Paxene approved for E.U. marketing; Paxoral shows positive results in phase I

FDA Advisory Committee votes against recommending Allergan therapy for dry eye disease

Arylthiazolidinedione PPAR agonists discovered at Merck

Neuroprotective agents from AstraZeneca possess novel mechanism of action

Triazine compound with anticonvulsant, analgesic and neuroprotective effects

Alcon's new prostaglandin analogues for glaucoma

Sunrise LTK System not recommended for FDA approval

Benzazepines synthesized at Zambon useful as antiallergic/antiinflammatory agents

MCP-1 receptor antagonists in early development at Takeda

Bexxar assigned priority review status by FDA

Potent melatonin receptor ligands synthesized and tested at ADIR

Novel AMPA/kainate antagonist protective in models of global and focal cerebral ischemia

Pharmacological profile of new NMDA receptor antagonist selective for NR2B subunit

BRAIN ' 99: dexanabinol may have potential in essential tremor

Cortecs and Towa terminate collaboration for Macritonin, milestone payment received by Cortecs

News from BRAIN '99: inhibition of VEGF activity represents novel antiischemic therapeutic strategy

SR-146131: new, orally active, potent and selective CCK1 agonist

Austrian lab presents preliminary results with new AChE inhibitor: SPH-1286

Novel silent antagonist of vascular 5-HT1B-like receptors identified during collaboration

Centocor to join the Johnson & Johnson family of companies

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...